Excess mortality for acute myocardial infarction in the United States during the first two years of the COVID-19 pandemic

Prog Cardiovasc Dis. 2024 Jul-Aug:85:120-121. doi: 10.1016/j.pcad.2024.03.006. Epub 2024 Mar 20.

Authors

Giuseppe Lippi¹, Fabian Sanchis-Gomar², Carl J Lavie³

Affiliations

¹ Section of Clinical Biochemistry and School of Medicine, University of Verona, Verona, Italy.
² Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: fabian.sanchis@uv.es.
³ John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, LA, USA.

PMID: 38519007
DOI: 10.1016/j.pcad.2024.03.006

No abstract available

Publication types

Letter

MeSH terms

Aged
COVID-19* / epidemiology
COVID-19* / mortality
Female
Humans
Male
Middle Aged
Myocardial Infarction* / epidemiology
Myocardial Infarction* / mortality
Pandemics
SARS-CoV-2
Time Factors
United States / epidemiology